Related Articles
Myeloid‑derived suppressor cells as targets of emerging therapies and nanotherapies (Review)
Screening and identification of potential target genes in head and neck cancer using bioinformatics analysis
Targeting BRD4: Potential therapeutic strategy for head and neck squamous cell carcinoma (Review)
Tumor microenvironment is not an ‘innocent bystander’ in the resistance to treatment of head and neck cancers (Review)
Molecular genetics of head and neck cancer (Review)